rxstat › Shortages › Avalglucosidase Alfa
Avalglucosidase Alfa (Nexviazyme) shortage status
No current shortage
An enzyme replacement therapy used to treat Pompe disease.
Shortage history
Reports by product
What's happening
There are no active shortage reports for Avalglucosidase Alfa.
Recent changes
- Oct 9, 2026 Shortage resolved
- Sep 17, 2026 Estimated end date pushed back : Sep 21, 2026 → Oct 5, 2026
- Aug 20, 2026 Estimated end date pushed back : Aug 25, 2026 → Sep 21, 2026
- Jul 27, 2026 Estimated end date pushed back : Jul 31, 2026 → Aug 25, 2026
- Jul 14, 2026 Status changed
- Jul 14, 2026 Estimated end date pushed back : Jul 20, 2026 → Jul 31, 2026
Common questions
What is Avalglucosidase Alfa used for?
An enzyme replacement therapy used to treat Pompe disease.
When will Avalglucosidase Alfa be back in stock in Canada?
Avalglucosidase Alfa has no active shortage; supply is normal per Health Canada reports.
Why is Avalglucosidase Alfa in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.